Literature DB >> 30137543

GBM Drug Bank-a new resource for glioblastoma drug discovery and informatics research.

Fredrik Svensson1, Bart Westerman2, Thomas Würdinger2, David Bailey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30137543      PMCID： PMC6231204          DOI： 10.1093/neuonc/noy122

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  4 in total

1.  Combination therapies in oncology.

Authors:  Rachel M Webster
Journal:  Nat Rev Drug Discov       Date:  2016-02       Impact factor: 84.694

Review 2.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.

Authors:  Michael R Barnes; Lee Harland; Steven M Foord; Matthew D Hall; Ian Dix; Scott Thomas; Bryn I Williams-Jones; Cory R Brouwer
Journal:  Nat Rev Drug Discov       Date:  2009-07-17       Impact factor: 84.694

Review 3.  Drug repurposing for the treatment of glioblastoma multiforme.

Authors:  Claudia Abbruzzese; Silvia Matteoni; Michele Signore; Luca Cardone; Kavindra Nath; Jerry D Glickson; Marco G Paggi
Journal:  J Exp Clin Cancer Res       Date:  2017-11-28

4.  PubChem Substance and Compound databases.

Authors:  Sunghwan Kim; Paul A Thiessen; Evan E Bolton; Jie Chen; Gang Fu; Asta Gindulyte; Lianyi Han; Jane He; Siqian He; Benjamin A Shoemaker; Jiyao Wang; Bo Yu; Jian Zhang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2015-09-22       Impact factor: 16.971
  4 in total
  1 in total

1.  Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells.

Authors:  Lavinia-Lorena Pruteanu; Liliya Kopanitsa; Dezső Módos; Edgars Kletnieks; Elena Samarova; Andreas Bender; Leonardo Dario Gomez; David Stanley Bailey
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.